CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
25.71
-0.25 (-0.96%)
At close: Aug 15, 2025, 3:59 PM
25.70
-0.04%
After-hours: Aug 15, 2025, 04:54 PM EDT
CG Oncology Common stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | 551K | 662K | 1.14M | 684K | 650K | 539K | 204K | 203K | 194K | 194K | n/a |
Cost of Revenue | 156K | 7K | 11K | 15K | -7.82M | -7.82M | 17K | 17K | 7.85M | 7.85M | 4K |
Gross Profit | 395K | 662K | 1.14M | 676K | 642K | 527K | -7.65M | -7.65M | -7.66M | -7.65M | -4K |
Operating Income | -157.29M | -134.4M | -114.67M | -95.55M | -81.72M | -68.19M | -55.45M | -45.83M | -31.36M | -19.04M | -9.31M |
Interest Income | 29.2M | 28.83M | 26.63M | 23.2M | 17.59M | 11.42M | 6.92M | 4.1M | 1.82M | 1.05M | n/a |
Pretax Income | -128.08M | -105.56M | -88.04M | -72.36M | -64.16M | -56.87M | -48.6M | -40.88M | -28.67M | -17.06M | -8.39M |
Net Income | -86.66M | -105.56M | -88.04M | -72.36M | -64.16M | -56.87M | -48.6M | -40.88M | -28.67M | -17.06M | -8.39M |
Selling & General & Admin | 52.62M | 42.7M | 33.7M | 25.01M | 18.61M | 13.6M | 9.89M | 8.53M | 6.22M | 3.73M | 1.65M |
Research & Development | 105.22M | 92.36M | 82.1M | 71.22M | 63.76M | 55.12M | 45.75M | 37.49M | 25.33M | 15.5M | 7.66M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -58K | -50K | -37K | -37K | 21K | 13K |
Operating Expenses | 157.84M | 135.06M | 115.8M | 96.22M | 82.36M | 68.72M | 55.64M | 46.02M | 31.55M | 19.23M | 9.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -4K | -8K | -8K | -12K | -8K | -8K | -8K | -4K | -4K |
Cost & Expenses | 157.84M | 135.06M | 115.81M | 96.23M | 82.37M | 68.73M | 55.65M | 46.03M | 31.56M | 19.23M | 9.31M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
Shares Outstanding (Diluted) | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
EPS (Basic) | -1.78 | -1.52 | -1.32 | -1.16 | -1.14 | -1.03 | -0.91 | -0.71 | -0.43 | -0.26 | -0.13 |
EPS (Diluted) | -1.78 | -1.52 | -1.29 | -1.13 | -1.11 | -1 | -0.91 | -0.71 | -0.43 | -0.26 | -0.13 |
EBITDA | -157.24M | -134.36M | -114.64M | -95.52M | -81.71M | -68.18M | -55.43M | -45.81M | -31.35M | -19.03M | -9.31M |
EBIT | -149.97M | -134.4M | -114.67M | -95.55M | -81.72M | -68.19M | -55.45M | -46.02M | -31.56M | -19.23M | -9.51M |
Depreciation & Amortization | 13K | 20K | n/a | 36K | 20K | 17K | 17K | 17K | 12K | 8K | 4K |